Early-Stage Biotech Value Creation: The Roles of Equity and Partnerships
leadershipandbiotechnology.blogspot.com · 9,379 words · saved by 2 readers
WARNING TO THE READER : this piece is REALLY LONG . Its genesis lay in my current efforts to develop a business/financing strategy fo...
WARNING TO THE READER: this piece is REALLY LONG. Its genesis lay in my current efforts to develop a business/financing strategy for Decibel Therapeutics. In that context, I have been giving thought to how others have been successful—and failed—in such endeavors. The piece starts with my thoughts. It is then followed by responses to these thoughts by three great thinkers (and friends) in the biotech industry: Mark Levin, John Maraganore, and Jeff Tong, who reviewed an earlier draft. My replies to their responses are also included. In fact, there are two rounds of responses and replies.…
saved by
related reading
- Tech vs Biotech - Celine Haliouacelinehh.com
- Anatomy of a Biotech Business Development Deal | Andreessen Horowitza16z.com
- Biotech Startups: Move Slow and Fix Things - Stanford Biotechnology Groupstanfordbiotechgroup.com
- Curious cases of financial engineering in biotechowlposting.com
- Hub-and-Spoke Biotechs: BridgeBio - by Elliot Hershbergcenturyofbio.com
- How to start a biotech company, in the words of the founding CEO of Genentechbaybridgebio.com
- .:: Phrack Magazine ::.phrack.org
- Biotech’s Dulcius Ex Asperis: The Way Through This Downturn - RApportrapport.bio
- ARCH Venture Partners Interview - USA Pharma & Biopharma 2021projects.gbreports.com
- Hub-and-Spoke Biotechs: BridgeBiocenturyofbio.com
- Fundraising for Founder-led Biotech – Matt Krisiloffmattkrisiloff.com
- The Biotech Delusion: Things No One Wants to Admitmattshlosberg.substack.com